Article Correctness Is Author's Responsibility: Early Disease Modifying Therapy Initiation Associated With Improved MS Relapse Control

The article below may contain offensive and/or incorrect content.

Early initiation of dimethyl fumarate and fingolimod may be associated with improved relapse control in multiple sclerosis relative to late therapy initiation.